AbbVie Inc.
ABBV
$245.69
$1.890.78%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 67.69% | -13.35% | -1.22% | -53.38% | -29.52% |
| Total Depreciation and Amortization | -4.85% | -3.77% | -2.95% | -1.27% | -2.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.45% | 18.95% | 1.15% | 151.54% | 107.08% |
| Change in Net Operating Assets | -38.51% | 69.62% | 15.10% | -17.71% | -4,190.77% |
| Cash from Operations | 1.16% | 29.41% | 1.19% | 26.34% | 3.46% |
| Capital Expenditure | -24.23% | -22.44% | -24.64% | -32.43% | -21.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 57.04% | 55.69% | 73.48% | 68.50% | -7.50% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -119.45% | -109.65% | -98.21% | -53.81% | 1,389.83% |
| Cash from Investing | 46.06% | 45.83% | 68.09% | 64.28% | -1.58% |
| Total Debt Issued | -33.06% | 54.15% | -57.71% | -40.96% | -42.17% |
| Total Debt Repaid | 43.50% | 27.68% | 34.38% | -36.66% | -26.27% |
| Issuance of Common Stock | 44.16% | 27.59% | -48.13% | -68.94% | -62.25% |
| Repurchase of Common Stock | -11.65% | -12.12% | 42.62% | 1.33% | -0.60% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.64% | -5.73% | -5.73% | -5.50% | -5.23% |
| Other Financing Activities | -38.83% | -59.00% | 352.38% | 208.00% | 152.55% |
| Cash from Financing | 7.27% | 38.99% | -144.18% | -450.88% | -482.12% |
| Foreign Exchange rate Adjustments | -1,700.00% | 155.26% | 164.62% | -475.00% | 105.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.53% | 132.70% | 95.95% | 73.00% | -252.44% |